Strength(s)-related to the current research Up to our knowledge, this study is the first to describe the diagnostic utility of hsa-miR-21-5p or hsa-miR-155-5p and as panel, in combination with AFP, for an enhanced and, hopefully, early diagnosis of clinical CHCV G4-related HCC and LC. The gene discussed is AFP; the disease is hepatocellular carcinoma.